The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients

A Algaba; PM Linares; Fernández-Contreras M Encarnación; A Figuerola; X Calvet; I Guerra; Pousa I de; M Chaparro; JP Gisbert; F Bermejo

The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients

A Algaba, PM Linares, Fernández-Contreras M Encarnación, A Figuerola, X Calvet, I Guerra, Pousa I de, M Chaparro, JP Gisbert, F Bermejo

Department of Medicine

Research output: Contribution to journal › Article › Research

22 Citations (Scopus)

Original language	English
Pages (from-to)	695-702
Journal	Inflamm Bowel Dis
Volume	20
Publication status	Published - 1 Jan 2014

Cite this

Algaba, A., Linares, PM., Encarnación, F.-C. M., Figuerola, A., Calvet, X., Guerra, I., de, P. I., Chaparro, M., Gisbert, JP., & Bermejo, F. (2014). The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients. Inflamm Bowel Dis, 20, 695-702.

@article{a3cd444bf3d946ac9c63057c8f06ea10,

title = "The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients",

author = "A Algaba and PM Linares and Encarnaci{\'o}n, \{Fern{\'a}ndez-Contreras M\} and A Figuerola and X Calvet and I Guerra and de, \{Pousa I\} and M Chaparro and JP Gisbert and F Bermejo",

year = "2014",

month = jan,

day = "1",

language = "English",

volume = "20",

pages = "695--702",

journal = "Inflamm Bowel Dis",

issn = "1078-0998",

publisher = "Oxford University Press",

}

The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients. / Algaba, A; Linares, PM; Encarnación, Fernández-Contreras M et al.
In: Inflamm Bowel Dis, Vol. 20, 01.01.2014, p. 695-702.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients

AU - Algaba, A

AU - Linares, PM

AU - Encarnación, Fernández-Contreras M

AU - Figuerola, A

AU - Calvet, X

AU - Guerra, I

AU - de, Pousa I

AU - Chaparro, M

AU - Gisbert, JP

AU - Bermejo, F

PY - 2014/1/1

Y1 - 2014/1/1

UR - https://www.scopus.com/pages/publications/84898733589

M3 - Article

SN - 1078-0998

VL - 20

SP - 695

EP - 702

JO - Inflamm Bowel Dis

JF - Inflamm Bowel Dis

ER -

The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients

Other files and links

Cite this